Improvement in the prognosis of cirrhotic patients admitted to an intensive care unit, a retrospective study

European Journal of Gastroenterology & Hepatology
Arnaud GalboisBertrand Guidet

Abstract

To examine how the outcomes of cirrhotic patients admitted to an ICU have changed over time. A retrospective study in a medical ICU during two separate 3-year periods [period 1 (P1): 1995-1998 and period 2 (P2): 2005-2008]. A total of 56 cirrhotic patients were admitted during P1 and 138 during P2, accounting for 2.3 and 4.5% of the total ICU admissions (P<0.01). Patients' characteristics were markedly different between the two periods: previous functional status improved (Knaus scale, A/B/C/D: P1 - 7.1%/53.6%/35.7%/3.6% vs. P2 - 28.2%/47.8%/22.5%/1.5%, P<0.01), the number of comorbidities decreased (Charlson: 1.79±2.22 vs. 1.02±1.40, P=0.02), the severity of cirrhosis increased [Child-Pugh: 8 (7-13) vs. 11 (8-13), P=0.04; Model for End-Stage Liver Disease: 16 (12-28) vs. 22 (15-31), P=0.02], and acute organ dysfunctions increased (Sequential Organ Failure Assessment: 7.3±5.6 vs. 11.3±5.5, P<0.01). The crude in-ICU mortality was similar during the two periods (39.3 vs. 41.3%, P=0.92). However, after adjustment for severity, in-ICU mortality was markedly decreased during P2 (odds ratio: 0.36 [0.15; 0.88], P=0.02). Cirrhotic patients admitted to the ICU have an improved outcome despite increased severity of liver disease. This im...Continue Reading

References

Aug 1, 1973·The British Journal of Surgery·R N PughR Williams
Jan 1, 1983·Intensive Care Medicine·G GoldfarbB Rueff
May 29, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·B BernardT Poynard
Aug 10, 2000·American Journal of Respiratory and Critical Care Medicine·J P KressJ B Hall
Feb 15, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·P S KamathW R Kim
Aug 2, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M WehlerR Strauss
Jan 17, 2002·The New England Journal of Medicine·E RiversUNKNOWN Early Goal-Directed Therapy Collaborative Group
May 25, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Juan G Abraldes, Jaime Bosch
Apr 12, 2003·Critical Care Medicine·Mitchell M LevyUNKNOWN SCCM/ESICM/ACCP/ATS/SIS
Jul 10, 2003·American Journal of Respiratory and Critical Care Medicine·Djillali AnnaneUNKNOWN CUB-Réa Network
Sep 10, 2003·Journal of Clinical Gastroenterology·Ming-Hung TsaiPang-Chi Chen
Oct 8, 2003·Intensive Care Medicine·Elie AzoulayUNKNOWN Outcomerea Study Group
Mar 5, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Ming-Chih HouShou-Dong Lee
Sep 7, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Nicolas CarbonellRaoul Poupon
Oct 26, 2005·Intensive Care Medicine·Damien du CheyronPierre Charbonneau
Aug 5, 2006·Alimentary Pharmacology & Therapeutics·E CholongitasA K Burroughs
Dec 7, 2007·Intensive Care Medicine·R Phillip DellingerJean-Louis Vincent
Mar 11, 2008·Lancet·Detlef Schuppan, Nezam H Afdhal
Sep 5, 2008·The New England Journal of Medicine·W Ray KimTerry M Therneau
Nov 4, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Thierry GustotRichard Moreau
Aug 31, 2010·Critical Care Medicine·Vincent DasGeorges Offenstadt

❮ Previous
Next ❯

Citations

Apr 23, 2013·Critical Care : the Official Journal of the Critical Care Forum·Bertrand SauneufFrédéric Pène
Nov 28, 2013·Journal of Hepatology·Eric LevesqueDidier Samuel
Jun 19, 2013·Clinics and Research in Hepatology and Gastroenterology·Arnaud GalboisBertrand Guidet
Apr 23, 2013·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Ranjeeta BahirwaniNaga Chalasani
Feb 24, 2015·Alimentary Pharmacology & Therapeutics·C J KarvellasUNKNOWN Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database Research Group
May 6, 2015·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Benoît DupontThông Dao
Jun 21, 2015·Annals of Intensive Care·Fabrice DaviaudFrédéric Pène
Jul 30, 2014·Journal of Critical Care·S FröhlichJ F Boylan
Jul 9, 2016·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Karl M Langberg, Tamar H Taddei
Oct 7, 2016·Annals of Intensive Care·Gaël PitonVincent Di Martino
Apr 16, 2014·Critical Care Medicine·Arnaud GalboisUNKNOWN Collège des Utilisateurs des Bases des données en Réanimation (CUB-Réa) Group
Apr 5, 2017·Annals of Intensive Care·Alex WarrenJoanne McPeake
Aug 15, 2018·Critical Care Medicine·Constantine J KarvellasUNKNOWN Chronic Liver Failure Consortium and European Foundation for the Study of Chronic Liver Failure
Feb 12, 2014·Current Opinion in Critical Care·Constantine J Karvellas, Sean M Bagshaw
Mar 23, 2017·Annals of Intensive Care·Delphine WeilUNKNOWN METAREACIR Group
Jan 18, 2020·BMC Gastroenterology·Yu-Feng HuangChien-Chang Liao
Nov 8, 2017·Liver International : Official Journal of the International Association for the Study of the Liver·Karl M LangbergTamar H Taddei
Jun 9, 2020·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Franck PourcineMehran Monchi
Sep 17, 2019·Anaesthesia Critical Care & Pain Medicine·E Weiss, L Velly

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.